Dr. Li obtained his PhD at school of Public Health, Chinese University of Hong Kong (CUHK), Hong Kong, China in 2010. He subsequently became a postdoctoral fellow in Institute of Digestive Disease of CUHK, focusing on researches in molecular basis and clinical implication of epigenetic alteration in gastrointestinal (GI) cancers. He joined the Lab of Cancer Precision Therapy, SYSUCC as an associate professor in Feb 2014. He was involved in several major research projects on epigenetic alteration in GI cancers as Principal Investigator or Co-investigator with more than 20 publications as fist- or co-author in peer reviewed journals including Hepatology, Gut, Cell Research, Oncogene, Cancer.